Research to develop a predicting system of mammalian subacute toxicity. (3) Construction of a predictive toxicokinetics

Chemosphere

Volumn 33, Issue 12, 1996, Pages 2441-2468

  Yamaguchi, Takaaki ^a   Yabuki, Masashi ^a   Saito, Shoji ^a   Watanabe, Tomoyuki ^a   Nishimura, Hiroshi ^a   Isobe, Naohiko ^a   Shono, Fumiaki ^a   Matsuo, Masatoshi ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL CHEMICAL;

ABSORPTION; ADIPOSE TISSUE; ALGORITHM; ARTICLE; BIOACCUMULATION; BLOOD; KIDNEY; KIDNEY CLEARANCE; LIVER; METABOLISM; MUSCLE; TARGET ORGAN; TOXICOKINETICS;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ALGORITHMS; ANIMALS; CHROMOSOME ABERRATIONS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HAZARDOUS SUBSTANCES; KIDNEY; LIVER; MUSCLES; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

MAMMALIA;

INDUSTRIAL CHEMICAL; MAMMAL; MODELLING; SUBACUTE TOXICITY; TOXICITY; TOXICOKINETICS MODEL;

EID: 0030301082     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(96)00342-6     Document Type: Article

References (33)

1. 1) Phillips JC, Gibson WB, Yam J et al., Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vitro LD50 test. Fd Chem Toxic. 1990; 28, 375-394.
2. 2) EPA Bulletin 1994; 15(2), 37
3. 3) The Ministry of International Trade & Industry, The guideline of "Law Concerning the Examination and Regulation of Manufacture, etc., of Chemical Substances; Testing Methods for New Chemical Substances (amended December 5, 1986), EHWD No. 5 (Director-general of Planning and Coodination Bureau, the Ministry of Environment Agency, Japan), PAB No. 615 (Director-general of Pharmaceutical Affairs Bureau, the Ministry of Health & welfare, Japan) and BIB No. 392 (Director-general of Basic Industries Bureau, the Ministry of International Trade & Industry, Japan)"
4. 4) Yamaguchi T, Nishimura H, Watanebe T, et al. A research to develop a predicting system of mammalian subacute toxicity : (1) Prediction of subacute toxicity using the biological parameters of acute toxicities. , Chemosphere, 1996; 32: 979-998.
5. 5) Yamaguchi T, Watanebe T, Sako H, et al. A research to develop a predicting system of mammalian subacute toxicity: (2) Singlre dose detailed toxicity studies., Chemosphere, 1996; 32: 999-1019.
6. 6) Mayer JM, van de Waterbeemd H. Development of quantitative structure-pharmacokinetic relationships. Env. Health Perspect. 1985; 61: 295-306.
7. 7) Lien EJ. Structure-absorption-distribution relationships: significance for drug design. In: Ariens E.J. eds. Drug Design. Academic Press, 1975; 81-131.
8. 8) Seydel JK, Schaper KJ. Quantitative structure-pharmacokinetic relationships and drug design. Pharmacol. Ther., 1982; 15: 131-182.
9. 9) Yabuki M, Mine T, Iba K, et al. Pharmaco-kinetics of SM-10888 and its metabolites depending on their physicochemical properties. Drug Metab. Dispos. 1994; 22: 294-297.
10. 10) Suzuki A, Higuchi WI, Ho NFH. Theoretical model studies of drug absorption and transport in the gastrointestinal tract. II. J. Pharm. Sci. 1970; 59: 651-59.
11. 11) Tsuji A. "Yakubutsuno kouzouto seitainai-doutaitono kankeino teiryouteki-kaiseki". In: Kouzou kassei soukan konwakai eds. Yakubutsuno kouzou kassei soukan (II), (Japanese original title) / Quantitative analysis of correlation between chemical structure and pharmacokinetics. In: Social Gathering Meeting of QSAR eds. QSAR for Pharmaceuticals (II), (English translation by author), Nanko-do, 1982.
12. 12) Sherrer RA, Howard SM. Use of distribution coefficients in quantitative structure-activity relationships. J. Med. Chem. 1977; 20: 53-58.
13. 13) Martin YC. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. J. Med. Chem. 1981; 24: 229-237.
14. 14) Kato R. "Iyakuhinno hikaku tainai-doutai". Yakubutsu-doutai kenkyu-kai eds., (Japanese original title) / Comparative pharmacokinetics of pharmaceuticals, Society of Pharmacokinetic eds., (English translation by author), Seishi-Shoin, 1984.
15. 15) Philipsen EK, Batsberg W, Christensen AB. Gastrointestinal permeability to polyethylene glycol: an evaluation of urinary recovery of an oral load of polyethylenglycol as a parameter of intestinal permeability in man. Eur. J. Clin. Inves. 1988; 18: 139-145.
16. 16) Donovan MD, Flynn GL, Amidon GL. Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastro-intestinal and nasal absorption. Pharm. Res. 1990; 7:9-14.
17. 17) Unpublished data.
18. 18) Sumitomo Chemical Co., Ltd. CSPS Technical Report (confidential report), 1992.
19. 19) Saito S, Matsuo M. The i/o characters related to the cohesive energy o organic chemicals. Chemosphere 1993; 27: 851-867.
20. 20) Fujita A. Prediction of organic compounds by conceptional diagram. Chem. Pharm. Bull. 1954; 2: 163-73.
21. 21) Fujita A. "Yuki-kagoubutsuno yosokuto yuki-gainenzu". (Japanese original title) / Prediction of organic compounds and its conceptional diagram. (English translation by author), Kagaku-no Ryouiki, 1957; 11: 719-725.
22. 22) Koda Y. "Yuki-gainenzu: Kiso-to-oyou". (Japanese original title) / Conceptional diagram of organic compounds (English translation by author), Sankyo-shuppan, 1984.
23. 23) Iga T. "Seiriteki toxicokinetics: Anzensei yosokuno-tameno dokusei-busshitsuno seitainai doutai-kaiseki". (Japanese original title) / Physiological toxicokinetics: Analysis of kinetics of toxic substances for safety evaluation. (English translation by author), Soft Science Press, 1981; 8: 1-26.
24. 24) Sawada Y. "Toxicokinetics-niyoru anzensei yosoku: Anzensei yosokuno-tameno dokusei-busshitsuno seitainai doutai-kaiseki". (Japanese original title) / Safety evaluation by toxicokinetics: Analysis of kinetics of toxic substances for safety evaluation. (English translation by author), Soft Science Press, 1981; 9: 1-27.
25. 25) Gargas ML, Burgess RJ, Voisard DE, et al. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 1989; 98: 87-99.
26. 26) Unpublished data.
27. 27) Unpublished data.
28. 28) Seydel JK, Trettin D, Cordes HP. Quantitative structure-pharmacokintic relationships derived on antibacterial sulfonamides in rats and its comparison to quantitative structure-activity relationships. J. Med. Chem. 1980; 23: 607-613.
29. 29) Yano Y, Yamaoka K, et al. Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse laplace transform (FILT), J. Pharmacokinet. Biopharm. 1989; 17: 179-202.
30. 30) Pomona College. Medical Chemistry Project, Claremont, California 91711, USA, log P Database and Med. Chem. Software (Program Clogp-3). CLOGP
31. 31) Perrin DD, Dempsey B, Serjeant EP. pKa prediction for or ganic acids and bases. 1981. Chapman and Hall.
32. 32) Yamaoka K. "Maikon-niyoru yakubutsu sokudoron nyumon. (Japanese original title) / Pharmacokinetics by micro computer for beginners. (English translation by author), Nanko-do, 1983: 73-90.
33. 33) Lin JH, Sugiyama Y, Awazu S. et al. Physiological pharamaco-kinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Pharmacokinet. Biopharm. 1982; 10: 649-661.